C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

被引:0
作者
MacEwen, EG
Kutzke, J
Carew, J
Pastor, J
Schmidt, JA
Tsan, R
Thamm, DH
Radinsky, R
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
c-Met; canine; human; osteosarcoma; hepatocyte growth factor; invasion; molecular determinants; scatter factor; urokinase plasminogen activator;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and - independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion ( scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated ( human) or constitutive ( canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 100 条
[1]   Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma [J].
Arihiro, K ;
Inai, K .
PATHOLOGY INTERNATIONAL, 2001, 51 (02) :100-106
[2]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[3]   Fibroblast growth factor-2 induces hepatocyte growth factor scatter factor expression in osteoblasts [J].
Blanquaert, F ;
Delany, AM ;
Canalis, E .
ENDOCRINOLOGY, 1999, 140 (03) :1069-1074
[4]   UROKINASE AND UROKINASE RECEPTOR - A PARACRINE AUTOCRINE SYSTEM REGULATING CELL-MIGRATION AND INVASIVENESS [J].
BLASI, F .
BIOESSAYS, 1993, 15 (02) :105-111
[5]   HEPATOCYTE GROWTH-FACTOR - A MULTIFUNCTIONAL CYTOKINE [J].
BOROS, P ;
MILLER, CM .
LANCET, 1995, 345 (8945) :293-295
[6]  
Bowers DC, 2000, CANCER RES, V60, P4277
[7]   3 ADDITIONAL DNA POLYMORPHISMS IN THE MET GENE AND D7S8 LOCUS - USE IN PRENATAL-DIAGNOSIS OF CYSTIC-FIBROSIS [J].
DEAN, M ;
OCONNELL, P ;
LEPPERT, M ;
PARK, M ;
AMOS, JA ;
PHILLIPS, DG ;
WHITE, R ;
WOUDE, GFV .
JOURNAL OF PEDIATRICS, 1987, 111 (04) :490-495
[8]  
DEBART ACW, 1995, J BONE MINER RES, V10, P1374
[9]  
DEVRIES TJ, 1994, AM J PATHOL, V144, P70
[10]  
DIRENZO MF, 1995, CLIN CANCER RES, V1, P147